Role of long term antibiotics & antimicrobial in diseases

Antibiotics have been applied for the treatment of autoimmune diseases for over five decades, based on the premise that infections play a role in the initiation and propagation of these entities. The antibiotics market was valued at USD 39.8 million in 2015 and is expected to witness a CAGR of 4.0% over the forecast period. Increasing efforts are being witnessed toward the development of advanced products. According to the data published by the Pew Charitable Trust, in March 2016, about 37 promising molecules were being investigated within the U.S. market. Majority of these, are in phase II clinical trials and are anticipated to hit the market between 2018 - 2020. Furthermore, supportive government legislations, such as the Generating Antibiotics Incentives Now (GAIN) Act are expected to expedite the approval process. GAIN Act has provisions which facilitate development of therapy against antibiotic resistant pathogens.

  • Antibiotics chronic respiratory diseases
  • Antibiotics chronic inflammatory diseases
  • Antibiotics in cancer
  • Antibiotics in Diabetes
  • Antibiotics in Pregnancy

Related Conference of Role of long term antibiotics & antimicrobial in diseases

Role of long term antibiotics & antimicrobial in diseases Conference Speakers